News
Treat HIV-Related Hodgkin's Like Non-HIV Disease
- Author:
- Sara Freeman
Major Finding: At 2-years, progression-free and overall survival rates were 91.7% and 90.2%, respectively, for the whole population.
News
Stopping Dasatinib and Nilotinib Explored in Chronic Myeloid Leukemia
- Author:
- Sara Freeman
Major Finding: At 6 months’ follow-up, 71% of patients achieved a stable MMR, and 64% remained treatment free.Data Source: Preliminary data on 14...
News
Rituximab Maintenance Called "New Standard" for Mantle Cell Lymphoma
- Author:
- Sara Freeman
Major Finding: After induction therapy, rituximab-treated patients experienced a median remission of 77 months, compared with 24 months in...
News
Rituximab Maintenance Called "New Standard" for Mantle Cell Lymphoma
- Author:
- Sara Freeman
Major Finding: After induction therapy, rituximab-treated patients experienced a median remission of 77 months, compared with 24 months in...
News
Rituximab Maintenance Called "New Standard" for Mantle Cell Lymphoma
- Author:
- Sara Freeman
Major Finding: After induction therapy, rituximab-treated patients experienced a median remission of 77 months, compared with 24 months in...
News
Black Osteoarthritis Patients Tend to Balk at Total Knee Replacement
- Author:
- Sara Freeman
Major Finding: The adjusted odds ratio for willingness to undergo TKR was 0.38 comparing black vs. white patients (95% CI, 0.19-0.74; P = .005)....
News
Black Osteoarthritis Patients Tend to Balk at Total Knee Replacement
- Author:
- Sara Freeman
Major Finding: The adjusted odds ratio for willingness to undergo TKR was 0.38 comparing black vs. white patients (95% CI, 0.19-0.74; P = .005)....
News
Biologics May Enhance Nonmedical Management of Arthritis
- Author:
- Sara Freeman
News
Biologics May Enhance Nonmedical Management of Arthritis
- Author:
- Sara Freeman
News
DANBIO: Anti-TNFs Do Not Up Overall Cancer Risk in Arthritis
- Author:
- Sara Freeman
Major Finding: The relative risk of developing a first cancer with anti-TNF therapy vs.
News
DANBIO: Anti-TNFs Do Not Up Overall Cancer Risk in Arthritis
- Author:
- Sara Freeman
Major Finding: The relative risk of developing a first cancer with anti-TNF therapy vs.
News
DANBIO: Anti-TNFs Do Not Up Overall Cancer Risk in Arthritis
- Author:
- Sara Freeman
Major Finding: The relative risk of developing a first cancer with anti-TNF therapy vs.
News
DANBIO: Anti-TNFs Do Not Up Overall Cancer Risk
- Author:
- Sara Freeman
Major Finding: The relative risk of developing a first cancer with anti-TNF therapy vs.
News
Hypothyroidism in Arthritis Patients Drives Up Cardiovascular Risk
- Author:
- Sara Freeman
Major Finding: Compared with controls, adjusted OR for CVD in female patients was 1.19 for those with hypothyroidism; 1.48 for those with IA, and...
News
Register of Epoch-Making Biologics Hits 10 Years
- Author:
- Sara Freeman